GRAY C EVANS Insider Trading $NVAX NOVAVAX INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GRAY C EVANS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GRAY C EVANS. GRAY C EVANS is Chairman, President & CEO in MAGNUM HUNTER RESOURCES INC ($MHR) and Director in NOVAVAX INC ($NVAX) and Chairman and CEO in MAGNUM HUNTER RESOURCES CORP ($PRC).
GRAY C EVANS in NOVAVAX INC
Trading Symbol: NVAXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GRAY C EVANS: Director
Holdings: 19,549 shares
Current Value: $25,609
Latest Transaction: Jun 22 2021
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GRAY C EVANS in NOVAVAX INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, PRC, MHR, NVAX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 0.00 | 3,450 | 0 | 0 | |
Jun 22 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 0.00 | 3,450 | 0 | 19,549 | 16.1 K to 19.5 K (+21.43 %) |
Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 3.99 | 18,000 | 71,730 | 0 | |
Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 46.00 | 4,500 | 207,000 | 0 | |
Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 99.80 | 2,000 | 199,600 | 0 | |
Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 212.00 | 14,768 | 3,130,816 | 16,099 | 30.9 K to 16.1 K (-47.84 %) |
Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 210.00 | 9,732 | 2,043,720 | 30,867 | 40.6 K to 30.9 K (-23.97 %) |
Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 3.99 | 18,000 | 71,730 | 40,599 | 22.6 K to 40.6 K (+79.65 %) |
Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 46.00 | 4,500 | 207,000 | 22,599 | 18.1 K to 22.6 K (+24.86 %) |
Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 99.80 | 2,000 | 199,600 | 18,099 | 16.1 K to 18.1 K (+12.42 %) |
Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 27.60 | 4,000 | 110,400 | 0 | |
Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 27.60 | 4,000 | 110,400 | 0 | |
Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 36.60 | 1,500 | 54,900 | 0 | |
Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 50.00 | 1,000 | 50,000 | 0 | |
Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 150.44 | 10,500 | 1,579,620 | 321,979 | 332.5 K to 322 K (-3.16 %) |
Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 27.60 | 4,000 | 110,400 | 332,479 | 328.5 K to 332.5 K (+1.22 %) |
Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 27.60 | 4,000 | 110,400 | 328,479 | 324.5 K to 328.5 K (+1.23 %) |
Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 36.60 | 1,500 | 54,900 | 324,479 | 323 K to 324.5 K (+0.46 %) |
Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 50.00 | 1,000 | 50,000 | 322,979 | 322 K to 323 K (+0.31 %) |
Jun 26 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 0.00 | 3,450 | 0 | 3,450 | |
Jun 26 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 83.54 | 6,900 | 576,426 | 6,900 | |
Jun 26 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 0.00 | 3,450 | 0 | 3,450 | |
Jun 26 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 83.54 | 6,900 | 576,426 | 6,900 | |
Dec 16 2019 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 3.99 | 18,000 | 71,820 | 18,000 | |
Dec 14 2018 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 2.30 | 90,000 | 207,000 | 90,000 | |
Dec 19 2017 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 1.38 | 80,000 | 110,400 | 80,000 | |
Mar 20 2017 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 1.38 | 80,000 | 110,400 | 80,000 | |
Jun 07 2016 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 6.50 | 18,998 | 123,487 | 321,979 | 341 K to 322 K (-5.57 %) |
May 25 2016 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 5.42 | 16,134 | 87,495 | 340,977 | 357.1 K to 341 K (-4.52 %) |
May 25 2016 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 5.40 | 33,866 | 182,876 | 357,111 | 391 K to 357.1 K (-8.66 %) |
Mar 17 2016 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 4.99 | 40,000 | 199,600 | 40,000 | |
Feb 18 2016 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 4.60 | 50,000 | 230,000 | 0 | |
Feb 18 2016 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 4.60 | 50,000 | 230,000 | 390,977 | 341 K to 391 K (+14.66 %) |
Aug 26 2015 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 11.24 | 20,000 | 224,808 | 340,977 | 361 K to 341 K (-5.54 %) |
Aug 17 2015 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 1.28 | 30,000 | 38,400 | 0 | |
Aug 17 2015 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 0.06 | 15,000 | 840 | 0 | |
Aug 17 2015 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 13.56 | 6,002 | 81,398 | 360,977 | 367 K to 361 K (-1.64 %) |
Aug 17 2015 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 1.28 | 30,000 | 38,400 | 366,979 | 337 K to 367 K (+8.90 %) |
Aug 17 2015 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 0.56 | 15,000 | 8,400 | 336,979 | 322 K to 337 K (+4.66 %) |
Mar 09 2015 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 8.94 | 40,000 | 357,600 | 40,000 |
Page: 1